Install
Cell & Gene Therapies
CAR‑T, CRISPR, in vivo delivery, manufacturing, and long‑term follow‑up.
- 4 Tracked terms
- Last 30 days Feed window
What this topic collects on
An article joins this feed when it matches these terms. Each one is also a search of its own.
Related topics
Latest in Cell & Gene Therapies
Dogs May Not Respond to Thalidomide, Genetic Study Warns
5+ hour, 58+ min ago (656+ words) Thalidomide is one of the most infamous drugs in modern medicine, a sedative withdrawn from the market in 1961 after causing severe birth defects in thousands of children....
CRISPR Methylation Editing Rewrites the Cancer Epigenome Toward Causation
19+ hour, 37+ min ago (67+ words) Cancer has long been understood as a disease of the genome, driven by mutations that rewire the instructions encoded in DNA. Over the past three decades, however, a parallel truth has crystallized: cancer is equally a disease of the epigenome,…...
FDA clears trial of dual-targeted CAR T-cell therapy for cancer
1+ day, 4+ hour ago (778+ words) The U.S. Food and Drug Administration this week granted permission for investigators at the University of Colorado Anschutz to conduct a clinical trial testing genetically engineered immune cells in adults with advanced colorectal cancer and pediatric patients with solid cancers who…...
CAR T-cell Therapy for NHL Clinical Trial Landscape Expands: Over 70 Companies Advancing Next-Generation Therapies | DelveInsight
2+ day, 9+ hour ago (184+ words) New York, USA, Sept. 10, 2026 (GLOBE NEWSWIRE) -- CAR T-cell Therapy for NHL Clinical Trial Landscape Expands: Over 70 Companies Advancing Next-Generation Therapies | DelveInsight The CAR T-cell therapy for NHL clinical trial analysis report delivers important insights into ongoing research of 75+ pipeline CAR…...
$3.3 million NIH grant funds Upstate research into new immunotherapy for leukemia
2+ day, 7+ hour ago (461+ words) Credit: SUNY Upstate Medical University Upstate immunologist Mobin Karimi, MD/PhD, has been awarded a $3.3 million grant to explore a new type of immunotherapy to treat acute myeloid leukemia. The grant comes from the National Cancer Institute of the National…...
Fifty years later, landmark Robert Gallo discovery recognized as a foundation for modern cancer immunotherapy
2+ day, 10+ hour ago (259+ words) New publication in Science examines how Dr. Gallo's 1976 discovery of T-cell growth factor, later known as IL-2, transformed T-cell immunology and cancer immunotherapy. A groundbreaking discovery by Robert C. Gallo, MD, half a century ago helped establish the scientific foundation for modern…...
Rare Disease Genome Editing Market to Hit USD 12.60 Billion by 2035, Growing at a CAGR of 11.28% - SNS Insider
2+ day, 11+ hour ago (487+ words) U.S. Rare Disease Genome Editing Market to Reach USD 3.60 Billion and Europe USD 3.42 Billion by 2035 as CRISPR Adoption, Gene Therapy Approvals, and Precision Medicine Drive Growth. Austin, United States, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Rare Disease Genome Editing Market Size & Growth Analysis: According…...
NIH awards $3.3 million to Upstate for new leukemia immunotherapy research
2+ day, 4+ hour ago (779+ words) The immune system’s ability to hunt down and destroy cancer cells depends on a delicate molecular recognition process, one that acute myeloid leukemia has become disturbingly good at evading....
MGX: Lead gene editing program targets Hemophilia A with durable efficacy and IND submission set for Q4
2+ day, 10+ hour ago (80+ words) TradingView MGX: Lead gene editing program targets Hemophilia A with durable efficacy and IND submission set for Q4 MGX-001 for Hemophilia A is advancing toward IND submission in Q4, with clinical entry targeted for 2027. Preclinical data show durable, dose-dependent Factor VIII expression…...
Encoded secures $275m for Dravet syndrome gene therapy
2+ day, 14+ hour ago (356+ words) Proceeds will go towards a pivotal trial of the candidate in paediatric patients. Encoded Therapeutics has raised $275m in a Series F financing round to advance development of its disease-modifying therapy (DMT) for Dravet syndrome, with an eye also on initiating…...